Category
News & Updates
News & UpdatesTOP 10 Pharmaceutical companies 2018
Here is a list of the top 10 pharmaceutical companies 2018 Hoffmann-La Roche Ltd (Switzerland) Pfizer (U.S.) AbbVie (U.S.) Johnson & Johnson (U.S.) Sanofi (France) Merck & Co. (U.S.) Novartis (Switzerland) Gilead Sciences (U.S.) GlaxoSmithKline (U.K.) Amgen (U.S.)
Mar 11, 2018
News & UpdatesBenznidazole first U.S. treatment for Chagas disease
Chagas disease Known as American trypanosomiasis, is a parasitic infection caused by Trypanosoma cruzi and can be transmitted through different routes, including contact with the feces of a certain insect, blood transfusions, or from a mother to her child during pregnancy. After years of infection, the disease can cause serious heart illness, and it also…
Aug 29, 2017
- News & Updates
Radicava (edaravone) approved for ALS by FDA
What is Radicava? Do you remember the Ice Bucket Challenge, the challenge that carried out by most famous people and passed to others as an awareness campaign for amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. Amyotrophic lateral sclerosis (ALS) ALS is a rare disease that attacks and kills the nerve cells…
May 5, 2017
- News & Updates
Bavencio approved by FDA for metastatic Merkel cell carcinoma (MCC)
“While skin cancer is one of the most common cancers, patients with a rare form called Merkel cell cancer have not had an approved treatment option until now,” said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and director of the…
Mar 23, 2017
- News & Updates
Amjevita approved by FDA for multiple inflammatory diseases.
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Abbvie product Humira (adalimumab) for multiple inflammatory diseases. Enbrel and Humira belong to a class of drugs that treating inflammation by blocking a protein known as tumor necrosis factor. Manufactured by Amgen. Amjevita is approved for the treatment of : moderately…
Sep 23, 2016
News & UpdatesJohnson & Johnson (J&J) to Acquire Abbott Medical Optics
J&J Acquisition is to Strengthen Global Leadership in Eye Health Adding Cataract and Refractive Eye Surgery to Vision Care Portfolio. J&J will pay $4.325 billion in cash.
Sep 17, 2016
News & UpdatesHappy day for Sanofi new drug Toujeo®
Sanofi , France based company got FDA approval of its new drug Toujeo®. Toujeo is once daily insulin based on widely used insulin glargine. February 27, 2015 , Sanofi announces a positive opinion from European Medicines Agency (EMA) recommending approval of Toujeo injection for treatment of type 1 and type 2 diabetic patients. Toujeo showed…
Feb 27, 2015
News & UpdatesNovoNordisk announces positive results with oral semaglutide
Novonordisk the leading Danish company for producing anti diabetic drugs announces positive results for phase II testing of the oral hypoglycemic semaglutide. In the trails semaglutide appeared to be safe and well tolerated with nausea and vomiting diminished over time. “We are very pleased with the results of this trial confirming the potential…
Feb 21, 2015